USA flag logo/image

An Official Website of the United States Government

A P. falciparum MSP1 p42/QS-21 malaria vaccine

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
54266
Program Year/Program:
2001 / STTR
Agency Tracking Number:
1R41AI049641-01
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ANTIGENICS, INC.
ANTIGENICS, INC. 34 COMMERCE WAY WOBURN, MA 01801
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2001
Title: A P. falciparum MSP1 p42/QS-21 malaria vaccine
Agency: HHS
Contract: PHS2001-2
Award Amount: $302,541.00
 

Abstract:

DESCRIPTION: (Adapted from Applicant's Abstract) Malaria is a disease which affects more than 300 million people each year and is fatal for 1.5 million. The overall objective of this STTR Phase I project is to produce a cGMP malaria vaccine consisting of the 42 kDa C-terminal polypeptide of P. falciparum merozoite surface protein-1 (MSP1.42) to be formulated with QS21 adjuvant for preclinical studies and a future clinical Phase I trial. Evidence is presented that MSP1.42/QS-21 protects against P. falciparum malaria in the Aotus monkey model. Data is also presented supporting the feasibility of large-scale MSP1.42 production in the baculovirus system and its purification by standard chromatography. The goals of the project are (1) production of master cell banks of insect cell lines for virus stock and polypeptide production, respectively; (2) preparation of a virus stock of recombinant MSP1.42 baculovirus; (3) production of bulk MSP1.42 antigen in a bioreactor; (4) purification of MSP1.42; (5) establishment of analytical methods to define product specifications; and (6) evaluation of the immunogenicity of the cGMP MSP1.42/QS21 formulation in mice and Aotus and of its efficacy in Aotus. These studies will provide cGMP material and preclinical information for a clinical trial of MSP1.42/QS21 during STTR Phase II. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Principal Investigator:

Sandra P. Chang
8087321477
sandrac@hawaii.edu

Business Contact:

Packard, melissa
7817213518
MPACKARD@AQUILABIO.COM
Small Business Information at Submission:

ANTIGENICS, INC.
34 COMMERCE WAY WOBURN, MA 01801-1065 WOBURN, MA 01801

EIN/Tax ID: 043307818
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
UNIVERSITY OF HAWAII
UNIVERSITY OF HAWAII
HONOLULU, HI 96750
RI Type: Nonprofit college or university